November 20, 2020

Pfizer, BioNTech to Submit Emergency Authorization Request to FDA Friday for COVID-19 Vaccine

(ABC News) – Pfizer and partner BioNTech announced they will submit a request on Friday to the U.S. Food and Drug Administration for emergency use authorization of their COVID-19 vaccine candidate. The submission, which is based on a vaccine efficacy … Read More

November 18, 2020

The Ethical Questions That Haunt Facial-Recognition Research

(Nature) – In September 2019, four researchers wrote to the publisher Wiley to “respectfully ask” that it immediately retract a scientific paper. The study, published in 2018, had trained algorithms to distinguish faces of Uyghur people, a predominantly Muslim minority … Read More

November 12, 2020

What’s Next for COVID-19 Apps? Governance and Oversight

(Science) – Many governments have seen digital health technologies as a promising tool to address coronavirus disease 2019 (COVID-19), particularly digital contact tracing (DCT) apps such as Bluetooth-based exposure notification apps that trace proximity to other devices (1) and GPS-based … Read More

November 12, 2020

Russia’s Claim of a Successful COVID-19 Vaccine Doesn’t Pass the ‘Smell Test,’ Critics Say

(Science) – Another day, another promising COVID-19 vaccine? A Russian institute announced today its vaccine candidate has had remarkable success in an efficacy trial, just 2 days after the widely celebrated news from Pfizer and BioNTech that their vaccine had greater … Read More

November 10, 2020

The Story of mRNA: How a Once-Dismissed Idea Became a Leading Technology in the Covid Vaccine Race

(STAT News) – But what the companies share may be bigger than their differences: Both are banking on a genetic technology that has long held huge promise but has so far run into biological roadblocks. It is called synthetic messenger … Read More